Cargando…
Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host
Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominan...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634654/ https://www.ncbi.nlm.nih.gov/pubmed/28957426 http://dx.doi.org/10.1371/journal.ppat.1006656 |
_version_ | 1783270135966990336 |
---|---|
author | Chopra-Dewasthaly, Rohini Spergser, Joachim Zimmermann, Martina Citti, Christine Jechlinger, Wolfgang Rosengarten, Renate |
author_facet | Chopra-Dewasthaly, Rohini Spergser, Joachim Zimmermann, Martina Citti, Christine Jechlinger, Wolfgang Rosengarten, Renate |
author_sort | Chopra-Dewasthaly, Rohini |
collection | PubMed |
description | Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominant Vpma lipoproteins via Xer1-mediated site-specific recombinations. Phase-Locked Mutants (PLMs) expressing single stable Vpma products served as first breakthrough tools in mycoplasmology to study the role of such sophisticated antigenic variation systems. Comparing the general clinical features of sheep infected with a mixture of phase-invariable PLMs (PLMU and PLMY) and the wild type strain, it was earlier concluded that Vpma phase variation is not necessary for infection. Conversely, the current study demonstrates the in vivo indispensability of Vpma switching as inferred from the Vpma phenotypic and genotypic analyses of reisolates obtained during sheep infection and necropsy. PLMY and PLMU stably expressing VpmaY and VpmaU, respectively, for numerous in vitro generations, switched to new Vpma phenotypes inside the sheep. Molecular genetic analysis of selected ‘switchover’ clones confirmed xer1 disruption and revealed complex new rearrangements like chimeras, deletions and duplications in the vpma loci that were previously unknown in type strain PG2. Another novel finding is the differential infection potential of Vpma variants, as local infection sites demonstrated an almost complete dominance of PLMY over PLMU especially during early stages of both conjunctival and intramammary co-challenge infections, indicating a comparatively better in vivo fitness of VpmaY expressors. The data suggest that Vpma antigenic variation is imperative for survival and persistence inside the immunocompetent host, and although Xer1 is necessary for causing Vpma variation in vitro, it is not a virulence factor because alternative Xer1-independent mechanisms operate in vivo, likely under the selection pressure of the host-induced immune response. This singular study highlights exciting new aspects of mycoplasma antigenic variation systems, including the regulation of expression by host factors. |
format | Online Article Text |
id | pubmed-5634654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-56346542017-10-30 Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host Chopra-Dewasthaly, Rohini Spergser, Joachim Zimmermann, Martina Citti, Christine Jechlinger, Wolfgang Rosengarten, Renate PLoS Pathog Research Article Despite very small genomes, mycoplasmas retain large multigene families encoding variable antigens whose exact role in pathogenesis needs to be proven. To understand their in vivo significance, we used Mycoplasma agalactiae as a model exhibiting high-frequency variations of a family of immunodominant Vpma lipoproteins via Xer1-mediated site-specific recombinations. Phase-Locked Mutants (PLMs) expressing single stable Vpma products served as first breakthrough tools in mycoplasmology to study the role of such sophisticated antigenic variation systems. Comparing the general clinical features of sheep infected with a mixture of phase-invariable PLMs (PLMU and PLMY) and the wild type strain, it was earlier concluded that Vpma phase variation is not necessary for infection. Conversely, the current study demonstrates the in vivo indispensability of Vpma switching as inferred from the Vpma phenotypic and genotypic analyses of reisolates obtained during sheep infection and necropsy. PLMY and PLMU stably expressing VpmaY and VpmaU, respectively, for numerous in vitro generations, switched to new Vpma phenotypes inside the sheep. Molecular genetic analysis of selected ‘switchover’ clones confirmed xer1 disruption and revealed complex new rearrangements like chimeras, deletions and duplications in the vpma loci that were previously unknown in type strain PG2. Another novel finding is the differential infection potential of Vpma variants, as local infection sites demonstrated an almost complete dominance of PLMY over PLMU especially during early stages of both conjunctival and intramammary co-challenge infections, indicating a comparatively better in vivo fitness of VpmaY expressors. The data suggest that Vpma antigenic variation is imperative for survival and persistence inside the immunocompetent host, and although Xer1 is necessary for causing Vpma variation in vitro, it is not a virulence factor because alternative Xer1-independent mechanisms operate in vivo, likely under the selection pressure of the host-induced immune response. This singular study highlights exciting new aspects of mycoplasma antigenic variation systems, including the regulation of expression by host factors. Public Library of Science 2017-09-28 /pmc/articles/PMC5634654/ /pubmed/28957426 http://dx.doi.org/10.1371/journal.ppat.1006656 Text en © 2017 Chopra-Dewasthaly et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Chopra-Dewasthaly, Rohini Spergser, Joachim Zimmermann, Martina Citti, Christine Jechlinger, Wolfgang Rosengarten, Renate Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title | Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title_full | Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title_fullStr | Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title_full_unstemmed | Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title_short | Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host |
title_sort | vpma phase variation is important for survival and persistence of mycoplasma agalactiae in the immunocompetent host |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634654/ https://www.ncbi.nlm.nih.gov/pubmed/28957426 http://dx.doi.org/10.1371/journal.ppat.1006656 |
work_keys_str_mv | AT chopradewasthalyrohini vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost AT spergserjoachim vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost AT zimmermannmartina vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost AT cittichristine vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost AT jechlingerwolfgang vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost AT rosengartenrenate vpmaphasevariationisimportantforsurvivalandpersistenceofmycoplasmaagalactiaeintheimmunocompetenthost |